Douglas S Ingram's Net Worth

$71.9 Million

Estimate Recalculated Jul 8, 2024 07:02PM EST

Who is Douglas S Ingram?

Douglas S Ingram has an estimated net worth of $71.9 Million. This is based on reported shares across multiple companies, which include Volcom Inc, ECC Capital CORP, Sarepta Therapeutics, Inc., Endo International plc, Relay Therapeutics, Inc., Nemus Bioscience, Inc., and ALLERGAN INC.

SEC CIK

Douglas S Ingram's CIK is 0001190644

Past Insider Trading and Trends

2015 was Douglas S Ingram's most active year for acquiring shares with 12 total transactions. Douglas S Ingram's most active month to acquire stocks was the month of January. 2015 was Douglas S Ingram's most active year for disposing of shares, totalling 22 transactions. Douglas S Ingram's most active month to dispose stocks was the month of February. 2014 saw Douglas S Ingram paying a total of $13,510,705.17 for 154,431 shares, this is the most they've acquired in one year. In 2014 Douglas S Ingram cashed out on 168,013.76 shares for a total of $10,451,146.94, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Volcom Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 23
Form 4
-100.00%
-2.50K
$24.50
-$61,250.00
0
Jun 16
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
May 5
Form 4
—
0
—
—
0
May 6
Form 4
—
0
—
—
0
May 8
Form 4
∞
2.5K
$19.25
$48,118.00
2.5K
Aug 3
Form 4
—
0
—
—
0
Jun 29
Form 3
—
0
—
—
0
No matching records found

ECC Capital CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
29.63K
$6.75
$199,995.75
29.63K
Feb 18
Form 3
—
0
—
—
0
No matching records found

Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $126.41

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.91%
25.23K
$79.36
$2,001,799.89
390.31K
Nov 3
Form 4
+7.36%
25.03K
$79.94
$2,000,578.44
365.08K
Nov 17
Form 4
-4.98%
-17.81K
$80.40
-$1,432,084.80
340.06K
Jun 26
Form 4
-9.40%
-37.14K
$170.49
-$6,332,680.56
357.87K
Dec 31
Form 4
-8.60%
-37.19K
$129.04
-$4,798,352.40
395.01K
Dec 31
Form 4
+3.91%
16.25K
$123.07
$2,000,160.32
432.2K
Aug 12
Form 4
+4.18%
16.7K
$120.39
$2,009,871.82
415.94K
Oct 30
Form 4
+4.17%
16K
$125.26
$2,004,211.20
399.25K
Aug 15
Form 4
-8.79%
-36.95K
$135.53
-$5,007,291.38
383.25K
Jun 26
Form 4
+9.98%
38.14K
$52.44
$1,999,956.72
420.2K
Nov 8
Form 4
+14.05%
47.06K
$42.50
$1,999,965.00
382.06K
Jul 27
Form 4
∞
335K
—
—
335K
Jun 26
Form 3
—
0
—
—
0
No matching records found

Endo International plc (ENDPQ) Snapshot price: $0.01

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+254.52%
12.45K
$11.49
-$131,997.12
17.34K
Jun 9
Form 4/A
∞
4.89K
$26.59
$130,025.10
4.89K
May 5
Form 4
∞
9.4K
$26.59
$250,025.77
9.4K
May 5
Form 3
—
0
—
—
0
No matching records found

Relay Therapeutics, Inc. (RLAY) Snapshot price: $8.77

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
May 19
Form 4
∞
25K
$20.00
$500,000.00
25K
Jul 20
Form 3
—
0
—
—
0
No matching records found